YTHDF2 and neoplasm: Genetically or pharmacologically impairing this histone lactylation of YTHDF2 not only inhibit proliferation and migration in vitro, but also reduces tumor size of orthotopic xenografts of ocular melanoma, reflecting the relevance of this modification in vivo (29).